877 filings
Page 7 of 44
SEC STAFF
ryey 6u27t1
13 Apr 21
SEC staff action: Order
12:00am
8-K
8v6 nc2yqlw
29 Mar 21
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
5:26pm
8-K
k5njmt699a s0xsar8
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B5
czdim1dy6fsrdnie
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
24fyst1cq0yqjwae4
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
pe87ae5w4mjtjsog
22 Mar 21
Entry into a Material Definitive Agreement
3:54pm
SEC STAFF
su2ncr3c1td6
16 Mar 21
SEC staff action: Order
12:00am
8-K
j28t5k3v7kk34pci b0m
19 Feb 21
Regulation FD Disclosure
4:39pm
S-8
c0nbcn
12 Feb 21
Registration of securities for employees
4:23pm
S-8
5hal1759u0hxvwozco
12 Feb 21
Registration of securities for employees
4:21pm
8-K
9rwdaz
9 Feb 21
Departure of Directors or Certain Officers
7:30am
8-K
99afp1m8g5qyf
31 Dec 20
Departure of Directors or Certain Officers
4:16pm
DEF 14C
qg76arhs3ga13ysi
29 Dec 20
Information statement
4:59pm
8-K
q4lq795v
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
8jb5zys092o24
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
EFFECT
ql6lq e7egio4nvqs
30 Sep 20
Notice of effectiveness
12:15am
8-K
mppq0f58tv6 35
29 Sep 20
Other Events
7:37am
CORRESP
2t1l8 lxw
28 Sep 20
Correspondence with SEC
12:00am